Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis

Objectives: To assess whether vitamin D supplementation in infancy reduces the risk of type 1 diabetes in later life. Methods: This was a systematic review and meta-analysis using Medline, Embase, Cinahl, Cochrane Central Register of Controlled Trials and reference lists of retrieved articles. The main outcome measure was development of type 1 diabetes. Controlled trials and observational studies that had assessed the effect of vitamin D supplementation on risk of developing type 1 diabetes were included in the analysis. Results: Five observational studies (four case-control studies and one cohort study) met the inclusion criteria; no randomised controlled trials were found. Meta-analysis of data from the case-control studies showed that the risk of type 1 diabetes was significantly reduced in infants who were supplemented with vitamin D compared to those who were not supplemented (pooled odds ratio 0.71, 95% CI 0.60 to 0.84). The result of the cohort study was in agreement with that of the meta-analysis. There was also some evidence of a dose-response effect, with those using higher amounts of vitamin D being at lower risk of developing type 1 diabetes. Finally, there was a suggestion that the timing of supplementation might also be important for the subsequent development of type 1 diabetes. Conclusion: Vitamin D supplementation in early childhood may offer protection against the development of type 1 diabetes. The evidence for this is based on observational studies. Adequately powered, randomised controlled trials with long periods of follow-up are needed to establish causality and the best formulation, dose, duration and period of supplementation.

[1]  A. Moncrieff.  Infant Feeding , 1948 .

[2]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[3]  H. Keen,et al.  The geography of diabetes mellitus. , 1984, British medical bulletin.

[4]  B. Hollis,et al.  Relationships among vitamin D, 25-hydroxyvitamin D, and vitamin D-binding protein concentrations in the plasma and milk of human subjects. , 1986, The Journal of clinical endocrinology and metabolism.

[5]  N Risch,et al.  Assessing the role of HLA-linked and unlinked determinants of disease. , 1987, American journal of human genetics.

[6]  M. Holick,et al.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. , 1988, The Journal of clinical endocrinology and metabolism.

[7]  M Blettner,et al.  Traditional reviews, meta-analyses and pooled analyses in epidemiology. , 1999, International journal of epidemiology.

[8]  N. Maclaren,et al.  Autoimmunity and diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[9]  C. Beaufort.  The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999 .

[10]  J. Tuomilehto,et al.  Worldwide increase in incidence of Type I diabetes – the analysis of the data on published incidence trends , 1999, Diabetologia.

[11]  T. S. Group.  Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus , 1999 .

[12]  P. Magnus,et al.  Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring , 2000, Diabetologia.

[13]  C. Hayes.  Vitamin D: a natural inhibitor of multiple sclerosis , 2000, Proceedings of the Nutrition Society.

[14]  C. Beaufort.  Variation and trends in incidence of childhood diabetes in Europe , 2000, The Lancet.

[15]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[16]  J. Norris.  Can the sunshine vitamin shed light on type 1 diabetes? , 2001, The Lancet.

[17]  A. Hämäläinen,et al.  The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  S. Harris.  Can vitamin D supplementation in infancy prevent type 1 diabetes? , 2002, Nutrition reviews.

[19]  L. Sebastiani,et al.  Environmental risk factors for type 1 diabetes in Rome and province , 2003, Archives of disease in childhood.

[20]  H. DeLuca,et al.  Vitamin D and autoimmune diabetes , 2003, Journal of cellular biochemistry.

[21]  F. Greer,et al.  Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. , 2003, Pediatrics.

[22]  L. C. Stene,et al.  Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. , 2003, The American journal of clinical nutrition.

[23]  J. Cerhan,et al.  Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.

[24]  L. Nguyễn,et al.  The role of vitamin D in protecting type 1 diabetes mellitus , 2005, Diabetes/metabolism research and reviews.

[25]  M. Uskoković,et al.  Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists , 2005 .

[26]  J. Stengård,et al.  Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland , 1992, Diabetologia.

[27]  S. Harris.  Vitamin D in type 1 diabetes prevention. , 2005, The Journal of nutrition.

[28]  A. Ziegler,et al.  Immunintervention bei neu diagnostiziertem Typ-1-Diabetes , 2006 .

[29]  C. Zipitis,et al.  Vitamin D deficiency: prevention or treatment? , 2006, Archives of Disease in Childhood.

[30]  L. Nyström,et al.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.

[31]  K. Gillespie.  Type 1 diabetes: pathogenesis and prevention , 2006, Canadian Medical Association Journal.

[32]  A. Ziegler,et al.  [Immunointervention in newly diagnosed type 1 diabetes]. , 2006, Deutsche medizinische Wochenschrift.

[33]  S. Taback,et al.  Feasibility of a Type 1 Diabetes Primary Prevention Trial Using 2000 IU Vitamin D3 in Infants from the General Population with Increased HLA‐Associated Risk , 2006, Annals of the New York Academy of Sciences.

[34]  V. Calcaterra,et al.  Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study , 2007, Acta Diabetologica.

[35]  M. Peakman,et al.  Translational Mini‐Review Series on Type 1 Diabetes: Immune‐based therapeutic approaches for type 1 diabetes , 2007, Clinical and experimental immunology.

[36]  J. Ludvigsson,et al.  Vitamin D supplementation and diabetes‐related autoimmunity in the ABIS study , 2007, Pediatric diabetes.

[37]  A. Ziegler,et al.  Infant Nutrition and Type 1 Diabetes , 2007 .

[38]  J. Kouba,et al.  Vitamin D and Diabetes , 2008, The Diabetes educator.